Oct 14

Under the Microscope: A Closer Look at Opportunities and Risks in Health Care

Recently, the optimism surrounding blockbuster weight-loss drugs has propelled a few mega-cap health care stocks to dizzying valuations. But the opportunities for profitable growth in the Health Care sector go far beyond headline-makers and market darlings. Join Harding Loevner Health Care analyst David Glickman as he explores some of the newer advancements shaping the future of health care—from the promise of mRNA technology in oncology to biologic drug contract manufacturing dynamics, AI in health care, and next generation innovations still flying under the radar.

Please join CFA Columbus in welcoming Mr. David Glickman, CFA, Co-Deputy Director of Research with Harding Loevner as our guest speaker.

David Glickman serves as co-deputy director of research and is also an analyst of Health Care companies. He joined Harding Loevner in 2018 and is a partner of the firm. David has nearly 25 years of industry experience, including previously serving as Sector Head, International Health Care at Calamos Investments and Head of Asia-Pacific Research at Mirae Asset Global Investments Ltd. in Hong Kong. He also worked in Health Care equity research for Sigma Capital Management, Arcoda Capital Management, and Cumberland Associates. David graduated from Harvard University with an AB in Economics and is a CFA Charterholder.

RSVP's due Wednesday October 8 by Noon!